Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | LL455 | PO / MO |
There were no adverse events, treatment or outcomes to this administration of Rotarix. A 3rd dose was ordered and given inadvertently.